Evonik and Cassava Sciences join forces to fight Alzheimer’s disease
Evonik to supply commercial quantities of simufilam, a drug candidate for the treatment of Alzheimer’s disease. The late clinical phase quantities will be produced at Evonik’s Tippecanoe site in the US ... MORE